TNFα-stimulation of cFos-activation of neurons in the solitary nucleus is suppressed by TNFR:Fc adsorbant construct in the dorsal vagal complex

Brain Research

Volumn 976, Issue 1, 2003, Pages 69-74

  Hermann, Gerlinda E ^a   Tovar, C Amy ^b   Rogers, Richard C ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Autonomic nervous system; Brain; Cytokines; Direct activation of NST neurons

Indexed keywords

ETANERCEPT; PROTEIN C FOS; TUMOR NECROSIS FACTOR ALPHA; HYBRID PROTEIN; IMMUNOGLOBULIN G; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EVOKED RESPONSE; GENE CONSTRUCT; MALE; MICROINJECTION; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT; REGULATORY MECHANISM; SOLITARY TRACT NUCLEUS; STOMACH FUNCTION; VAGUS NERVE DORSAL NUCLEUS; VALIDATION PROCESS; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LONG EVANS RAT; MEDULLA OBLONGATA; METABOLISM; NERVE CELL; PHYSIOLOGY; VAGUS NERVE;

ANIMALS; IMMUNOGLOBULIN G; INJECTIONS, INTRAVENTRICULAR; MALE; MEDULLA OBLONGATA; MICROINJECTIONS; NEURONS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, LONG-EVANS; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS; SOLITARY NUCLEUS; TUMOR NECROSIS FACTOR-ALPHA; VAGUS NERVE;

EID: 0038743070     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02687-8     Document Type: Article

References (38)

1. Broadwell R.D., Sofroniew M.V. Serum proteins bypass the blood-brain fluid barriers for extracellular entry to the central nervous system. Exp. Neurol. 120:1993;245-263.
2. Buelke-Sam J., Holson J.F., Bazare J.J., Young J.F. Comparative stability of physiological parameters during sustained anesthesia in rats. Lab. Anim. Sci. 28:1978;157-162.
3. Coelho A., Fioramonti J., Bueno L. Brain interleukin-1beta and tumor necrosis factor-alpha are involved in lipopolysaccharide-induced delayed rectal allodynia in awake rats. Brain Res. Bull. 52:2000;223-228.
4. Emch G.S., Hermann G.E., Rogers R.C. TNF-alpha activates solitary nucleus neurons responsive to gastric distension. Am. J. Physiol. Gastrointest. Liver Physiol. 279:2000;G582-G586.
5. Emch G.S., Hermann G.E., Rogers R.C. TNF-alpha-induced c-Fos generation in the nucleus of the solitary tract is blocked by NBQX and MK-801. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281:2001;R1394-R1400.
6. Fioramonti J., Bueno L. Centrally acting agents and visceral sensitivity. Gut. 51:(Suppl. 1):2002;i91-i95.
7. Grassi F., Mileo A.M., Monaco L., Punturieri A., Santoni A., Eusebi F. TNF-alpha increases the frequency of spontaneous miniature synaptic currents in cultured rat hippocampal neurons. Brain Res. 659:1994;226-230.
8. Gross P.M., Wall K.M., Pang J.J., Shaver S.W., Wainman D.S. Microvascular specializations promoting rapid interstitial solute dispersion in nucleus tractus solitarius. Am. J. Physiol. 259:1990;R1131-R1138.
9. Harper A.A., Kidd C., Scratcherd T. Vago-vagal reflex effects on gastric and pancreatic secretion and gastro-intestinal motility. J. Physiol. (Lond.). 148:1959;417-436.
10. Hermann G., Rogers R.C. Tumor necrosis factor-alpha in the dorsal vagal complex suppresses gastric motility. Neuroimmunomodulation. 2:1995;74-81.
11. Hermann G.E., Emch G.S., Tovar C.A., Rogers R.C. c-Fos generation in the dorsal vagal complex after systemic endotoxin is not dependent on the vagus nerve. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280:2001;R289-R299.
12. Hermann G.E., Tovar C.A., Rogers R.C. Induction of endogenous tumor necrosis factor-alpha: suppression of centrally stimulated gastric motility. Am. J. Physiol. 276:1999;R59-R68.
13. Hermann G.E., Tovar C.A., Rogers R.C. LPS-induced suppression of gastric motility relieved by TNFR:Fc construct in dorsal vagal complex. Am. J. Physiol. Gastrointest. Liver Physiol. 283:2002;G634-G639.
14. Janz L.J., Brown R., Zuo L., Falk J., Greenberg A.H., Dyck D.G. Conditioned taste aversion but not adrenal activity develops to ICV administration of interleukin-1 in rats. Physiol. Behav. 49:1991;691-694.
15. Kalia M. Brain stem localization of vagal preganglionic neurons. J. Auton. Nerv. Syst. 3:1981;451-481.
16. Kalia M., Mesulam M.M. Brain stem projections of sensory and motor components of the vagus complex in the cat: I. The cervical vagus and nodose ganglion. J. Comp. Neurol. 193:1980;435-465.
17. Keppel G. Data transformations. Design and Analysis: A Researcher's Handbook. 1973;556-559 Prentice-Hall, Englewood Cliffs, NJ.
18. Kinouchi K., Brown G., Pasternak G., Donner D.B. Identification and characterization of receptors for tumor necrosis factor-alpha in the brain. Biochem. Biophys. Res. Commun. 181:1991;1532-1538.
19. Kotanidou A., Choi A.M., Winchurch R.A., Otterbein L., Fessler H.E. Urethane anesthesia protects rats against lethal endotoxemia and reduces TNF-alpha release. J. Appl. Physiol. 81:1996;2305-2311.
20. Mascarucci P., Perego C., Terrazzino S., De Simoni M.G. Glutamate release in the nucleus tractus solitarius induced by peripheral lipopolysaccharide and interleukin-1 beta. Neuroscience. 86:1998;1285-1290.
21. Moreland L.W. Soluble tumor necrosis factor receptor (p75) fusion protein (ENBREL) as a therapy for rheumatoid arthritis. Rheum. Dis. Clin. North Am. 24:1998;579-591.
22. Mueller H. Tumor necrosis factor as an antineoplastic agent: pitfalls and promises. Cell Mol. Life Sci. 54:1998;1291-1298.
23. Nadeau S., Rivest S. Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier. Neuroscience. 93:1999;1449-1464.
24. Rinaman L., Verbalis J.G., Stricker E.M., Hoffman G.E. Distribution and neurochemical phenotypes of caudal medullary neurons activated to express cFos following peripheral administration of cholecystokinin. J. Comp. Neurol. 338:1993;475-490.
25. R.C. Rogers, K.N. Browning, R.A. Travagli, Effects of tumor necrosis factor alpha on rat dorsal motor nucleus of the vagus neurons, Neuroscience Abstr. (2001) 634.11.
26. Rogers R.C., Hermann G.E. Central connections of the hepatic branch of the vagus nerve: a horseradish peroxidase histochemical study. J. Auton. Nerv. Syst. 7:1983;165-174.
27. Rogers R.C., Hermann G.E. Vagal afferent stimulation-evoked gastric secretion suppressed by paraventricular nucleus lesion. J. Auton. Nerv. Syst. 13:1985;191-199.
28. Rogers R.C., Kita H., Butcher L.L., Novin D. Afferent projections to the dorsal motor nucleus of the vagus. Brain Res. Bull. 5:1980;365-373.
29. Rogers R.C., McCann M.J. Intramedullary connections of the gastric region in the solitary nucleus: a biocytin histochemical tracing study in the rat. J. Auton. Nerv. Syst. 42:1993;119-130.
30. Rogers R.C., McTigue D.M., Hermann G.E. Vagovagal reflex control of digestion: afferent modulation by neural and 'endoneurocrine' factors. Am. J. Physiol. 268:1995;G1-10.
31. Shapiro R.E., Miselis R.R. The central organization of the vagus nerve innervating the stomach of the rat. J. Comp. Neurol. 238:1985;473-488.
32. Streefland C., Jansen K. Intramedullary projections of the rostral nucleus of the solitary tract in the rat: gustatory influences on autonomic output. Chem. Senses. 24:1999;655-664.
33. Szelenyi J. Cytokines and the central nervous system. Brain Res. Bull. 54:2001;329-338.
34. Tkacs N.C., Li J., Strack A.M. Central amygdala Fos expression during hypotensive or febrile, nonhypotensive endotoxemia in conscious rats. J. Comp. Neurol. 379:1997;592-602.
35. K.J. Tracey, A. Cerami, Pleiotropic effects of TNF in infection and neoplasia: beneficial, inflammatory, catabolic, or injurious. In: B.B. Agarioul, J. Vilcek (Eds.), Tumor Necrosis Factors: Structure, Function, and Mechanisms of Action, Dekker, New York, 1991, pp. 431-452.
36. Turrin N.P., Plata-Salaman C.R. Cytokine-cytokine interactions and the brain. Brain Res. Bull. 51:2000;3-9.
37. Waage A. Production and clearance of tumor necrosis factor in rats exposed to endotoxin and dexamethasone. Clin. Immunol. Immunopathol. 45:1987;348-355.
38. Winkler U., Jensen M., Manzke O., Schulz H., Diehl V., Engert A. Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8). Blood. 94:1999;2217-2224.